Kristin Stafford

Kristin Stafford

Director of Finance/CFO at ZYMEWORKS INC.

Net worth: 365 797 $ as of 2026-09-29

44 year
Health Technology
Commercial Services
Consumer Services

Profile

Ms. Kristin Stafford, CPA, is a Chief Financial Officer & Executive Vice President at Zymeworks, Inc., an Independent Director at NovoCure Ltd. and a Chief Accounting Officer & Senior Vice President at Royalty Pharma Plc.
She is on the Board of Directors at Theravance Biopharma, Inc. and NovoCure Ltd. Ms. Stafford was previously employed as a Chief Financial Officer by BioPharma Credit PLC, a Director-Capital Markets by Ernst & Young LLP (United Kingdom), and an Auditor by Deloitte & Touche LLP.
She received her undergraduate degree from Sonoma State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-02 22,934 ( 0.02% ) 365 797 $ 2026-09-29

Kristin Stafford active positions

CompaniesPositionStart
ROYALTY PHARMA PLC Comptroller/Controller/Auditor 2018-11-30
NOVOCURE LIMITED Director/Board Member 2023-03-27
ZYMEWORKS INC. Director of Finance/CFO 2026-03-31
THERAVANCE BIOPHARMA Director/Board Member 2026-09-22

Former positions of Kristin Stafford

CompaniesPositionEnd
BIOPHARMA CREDIT PLC Director of Finance/CFO 2017-12-31
Corporate Officer/Principal 2016-11-30
Comptroller/Controller/Auditor 2008-04-30
See the detail of Kristin Stafford's experience

Education of Kristin Stafford

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Kristin Stafford